BR9815178A - Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção - Google Patents

Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção

Info

Publication number
BR9815178A
BR9815178A BR9815178-9A BR9815178A BR9815178A BR 9815178 A BR9815178 A BR 9815178A BR 9815178 A BR9815178 A BR 9815178A BR 9815178 A BR9815178 A BR 9815178A
Authority
BR
Brazil
Prior art keywords
compound
nkt cells
autoimmunosuppressive
production
increase
Prior art date
Application number
BR9815178-9A
Other languages
English (en)
Inventor
Taro Masunaga
Takashi Tojo
Yuka Sasagawa
Nobuo Seki
Kiyoshi Tsuji
Glen W Spears
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9815178A publication Critical patent/BR9815178A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"AUTOIMUNOSUPRESSORES E/OU POTENCIALIZADOR MEDIADO PELO AUMENTO DE CéLULAS NKT, COMPOSTO E PROCESSO PARA SUA PRODUçãO". é provido um autoimunosupressor e/ou potencializador mediado pelo aumento do número de células NKT sobre respostas imunes normais, tipicamente compreendendo um composto da seguinte fórmula geral ou um sal farmaceuticamente aceitável do mesmo como ingrediente ativo. [onde R¹ representa hidrogênio ou halogênio, R² representa hidroxi, R^ 3^ representa alquila inferior, R^ 4^ representa alquila inferior, R^ 5^ representa hidrogênio ou alcoxi inferior, e Z representa O ou S]. é também provido um processo novo para sintetizar o composto acima.
BR9815178-9A 1997-12-15 1998-12-11 Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção BR9815178A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34540997 1997-12-15
PCT/JP1998/005604 WO1999030711A1 (fr) 1997-12-15 1998-12-11 Medicaments augmentant les cellules nkt

Publications (1)

Publication Number Publication Date
BR9815178A true BR9815178A (pt) 2000-10-10

Family

ID=18376408

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815178-9A BR9815178A (pt) 1997-12-15 1998-12-11 Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção

Country Status (8)

Country Link
EP (1) EP1048296A1 (pt)
KR (1) KR20010032855A (pt)
CN (1) CN1284878A (pt)
AU (1) AU1506099A (pt)
BR (1) BR9815178A (pt)
CA (1) CA2312406A1 (pt)
HU (1) HUP0100407A3 (pt)
WO (1) WO1999030711A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007191495A (ja) * 2001-10-22 2007-08-02 Santen Pharmaceut Co Ltd 掻痒治療剤
RU2309944C1 (ru) * 2006-04-12 2007-11-10 Общество с ограниченной ответственностью "ИФОХИМ" Производные пара-метоксианилинов, повышающие стойкость углеводородных топлив к детонации, и топливная композиция (варианты)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
GB9404378D0 (en) * 1994-03-07 1994-04-20 Fujisawa Pharmaceutical Co Quinoline derivatives

Also Published As

Publication number Publication date
CN1284878A (zh) 2001-02-21
HUP0100407A3 (en) 2002-01-28
KR20010032855A (ko) 2001-04-25
AU1506099A (en) 1999-07-05
WO1999030711A1 (fr) 1999-06-24
HUP0100407A2 (hu) 2001-07-30
EP1048296A1 (en) 2000-11-02
CA2312406A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
TR199501253A2 (tr) Amino(tio) eter türevleri.
FI950309A (fi) Proliiniamidijohdannaisia
ECSP930999A (es) Nuevos compuestos utilizables como agentes edulcorantes, su procedimiento de preparacion
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
DK0423714T3 (da) Hårrevitaliseringsmiddel
PT928788E (pt) Compostos farmaceuticamente activos
ES2006142A6 (es) Un metodo para preparar derivados de acidos quinolincarboxilicos
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE69511424D1 (de) Antifungale sordaridinderivate
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
AU541811B2 (en) Quinazoline derivatives
ES465034A1 (es) Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos.
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
BR9815178A (pt) Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção
ATE222246T1 (de) Benzoamid-derivat, antiulcus und antibakterielle mittel
DK0466662T3 (da) 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser
ATE40117T1 (de) O-substituierte 3-oxypyridiniumsalze, verfahren zu ihrer herstellung und ihre verwendung als fungizide fuer den pflanzenschutz.
YU43499A (sh) Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline
JPS5436287A (en) Thiadiazolylthiooxacephalosporin
AU3932297A (en) N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]